Davis JM - Search Results

1

Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.

Weiser M, Levi L, Burshtein S, Hagin M, Matei VP, Podea D, Micluția I, Tiugan A, Păcală B, Grecu IG, Noy A, Zamora D, Davis JM. Weiser M, et al. Among authors: davis jm. J Clin Psychiatry. 2017 Jul;78(7):e758-e765. doi: 10.4088/JCP.15m10498. J Clin Psychiatry. 2017. PMID: 28541645 Clinical Trial.

2

Monoamine oxidase and cortisol response in depression and schizophrenia.

Pandey GN, Sharma RP, Janicak PG, Davis JM. Pandey GN, et al. Among authors: davis jm. Psychiatry Res. 1992 Oct;44(1):1-8. doi: 10.1016/0165-1781(92)90064-a. Psychiatry Res. 1992. PMID: 1461943

3

Increased 3H-clonidine binding in the platelets of patients with depressive and schizophrenic disorders.

Pandey GN, Janicak PG, Javaid JI, Davis JM. Pandey GN, et al. Among authors: davis jm. Psychiatry Res. 1989 Apr;28(1):73-88. doi: 10.1016/0165-1781(89)90199-6. Psychiatry Res. 1989. PMID: 2544917

4

Plasma and CSF HVA before and after pharmacological treatment.

Sharma R, Javaid JI, Janicak P, Faull K, Comaty J, Davis JM. Sharma R, et al. Among authors: davis jm. Psychiatry Res. 1989 Apr;28(1):97-104. doi: 10.1016/0165-1781(89)90201-1. Psychiatry Res. 1989. PMID: 2740469

5

Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.

Janicak PG, Pandey GN, Sharma R, Boshes R, Bresnahan D, Davis JM. Janicak PG, et al. Among authors: davis jm. J Clin Psychiatry. 1987 Dec;48(12):480-2. J Clin Psychiatry. 1987. PMID: 3693333

6

Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders.

Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL Jr, Davis JM, Lewis DA. Haywood TW, et al. Among authors: davis jm. Am J Psychiatry. 1995 Jun;152(6):856-61. doi: 10.1176/ajp.152.6.856. Am J Psychiatry. 1995. PMID: 7755114

7

CSF and plasma MHPG, and CSF MHPG index: pretreatment levels in diagnostic groups and response to somatic treatments.

Sharma RP, Javaid JI, Faull K, Davis JM, Janicak PG. Sharma RP, et al. Among authors: davis jm. Psychiatry Res. 1994 Jan;51(1):51-60. doi: 10.1016/0165-1781(94)90046-9. Psychiatry Res. 1994. PMID: 7910975

8

Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder: the effects of antipsychotic treatment.

Sharma RP, Bissette G, Janicak P, Davis JM, Nemeroff CB. Sharma RP, et al. Among authors: davis jm. Schizophr Res. 1994 Sep;13(2):173-7. doi: 10.1016/0920-9964(94)90099-x. Schizophr Res. 1994. PMID: 7986775

9

Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment.

Pandey SC, Sharma RP, Janicak PG, Marks RC, Davis JM, Pandey GN. Pandey SC, et al. Among authors: davis jm. Psychiatry Res. 1993 Jul;48(1):57-68. doi: 10.1016/0165-1781(93)90113-u. Psychiatry Res. 1993. PMID: 8105499

10

Elevation of CSF somatostatin concentrations in mania.

Sharma RP, Bissette G, Janicak PG, Davis JM, Nemeroff CB. Sharma RP, et al. Among authors: davis jm. Am J Psychiatry. 1995 Dec;152(12):1807-9. doi: 10.1176/ajp.152.12.1807. Am J Psychiatry. 1995. PMID: 8526251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,143 results

Search Page

Filters